Tag: COVID-19

Social media platforms and those spreading deliberate vaccine misinformation should be held accountable and potentially face criminal sanctions, says Professor Melinda Mills...

However, UK supermarkets and online retailers made an additional £4 billion each thanks to the coronavirus lockdown that began in March last year, according to econometric models.

Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine, University of Oxford, and Joint Chief Investigator for the trial...

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019...

ETH researchers have drastically improved existing proteomics techniques so they can capture all functional alterations in proteins.

The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.

Who gets priority? If the pandemic is hitting certain communities harder, can they be adequately supplied with vaccine doses?

Today’s world is undergoing momentous changes, and managers are required to be able to grasp the profound nature of change, to anticipate scenarios.

The Neubauer Collegium for Culture and Society has opened My Kingdom for a Title, a new solo exhibition featuring work by Pope. L, an acclaimed artist and scholar in the University of Chicago’s Department of Visual Arts.

The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.